Skip to content
Screener

Ceva CEVA Total Revenue

Total Revenue at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$39K+388%
Marriott International logo
Marriott InternationalMAR
$1.4B+12.1%
Biogen logo
BiogenBIIB
$963.3M-13.0%
PTH
Pelthos TherapeuticsPTHS
$10.67M
Life Time Group Holdings logo
Life Time Group HoldingsLTH
$837.4M+13.8%
iRadimed logo
iRadimedIRMD
$15.39M+18.7%

Segments

By segment

See full
Connectivity Products$25.22M+34.0%
Smart Sensing Products$4.01M-25.1%

By geography

See full
Asia Pacific$17.2M-5.1%
Europe And Middle East$937K-53.4%

By product

See full
License$18.22M+21.3%
Royalty$10.81M+1.5%

Other financials

Income statement

See full
Gross profit$25.4M+14.7%
Operating income-$2.1M+53.7%
Net income-$2.9M+21.4%
EPS (diluted)-$0.21-200%

Balance sheet

See full
Cash & equivalents$44.3M+52.3%
Total debt$17.4M+299%
Total equity$340.2M+28.0%
Total assets$391.9M+29.4%

Cash flow

See full
Operating cash flow$5.8M
CapEx$634.0K-8.2%
Free cash flow-$7.2M+6.7%

Valuation

See full
Market cap$1.08B+107%
Enterprise value$1.05B+112%
P/S9.3×+4.4×

Profitability

See full
Gross margin89.9%
Operating margin-0.3%
Net margin-9.5%0.0pp
FCF margin1%

Returns & leverage

See full
Return on equity-3.6%-0.2pp
Debt / equity0.1×0.0×
Current ratio10.1×+1.5×

Where this comes from

Reported directly by Ceva in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Ceva’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437749-26-026774
Line itemSix months ended / June 30, 2026Six months ended / June 30, 2025Three months ended / June 30, 2026Three months ended / June 30, 2025
Revenues:
Licensing and related revenues$36,041$30,064$18,221$15,022
Royalties20,01619,85910,81210,656
Total revenues56,05749,92329,03325,678
Cost of revenues7,3757,0363,6463,549
Gross profit48,68242,88725,38722,129
Operating expenses:
Research and development, net39,16936,36719,33218,758

Item 1. FINANCIAL STATEMENTS

FAQ

What is Ceva's total revenue?
Ceva (CEVA) reported total revenue of $29.03M in Q2 2026.
How has Ceva's total revenue changed year-over-year?
Ceva's total revenue increased by 13.1% year-over-year, from $25.68M to $29.03M.
What is the long-term trend for Ceva's total revenue?
Over 4 years (2021 to 2025), Ceva's total revenue has grown at a -2.8% compound annual growth rate (CAGR), from $122.71M to $109.6M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Ceva's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude